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Antidepressants (ADs) are used as first-line treatment for most stress-related psychiatric
disorders. The alterations in brain circuit dynamics that can arise from stress exposure
and underlie therapeutic actions of ADs remain, however, poorly understood. Here,
enabled by a recently developed voltage-sensitive dye imaging (VSDI) assay in mouse
brain slices, we examined the impact of chronic stress and concentration-dependent
effects of eight clinically used ADs (belonging to different chemical/functional classes)
on evoked neuronal activity propagations through the hippocampal trisynaptic circuitry
(HTC: perforant path → dentate gyrus (DG) → area CA3 → area CA1). Exposure of
mice to chronic social defeat stress led to markedly weakened activity propagations
(“HTC-Waves”). In contrast, at concentrations in the low micromolar range, all ADs,
which were bath applied to slices, caused an amplification of HTC-Waves in CA
regions (invariably in area CA1). The fast-acting “antidepressant” ketamine, the mood
stabilizer lithium, and brain-derived neurotrophic factor (BDNF) exerted comparable
enhancing effects, whereas the antipsychotic haloperidol and the anxiolytic diazepam
attenuated HTC-Waves. Collectively, we provide direct experimental evidence that
chronic stress can depress neuronal signal flow through the HTC and demonstrate
shared opposing effects of ADs. Thus, our study points to a circuit-level mechanism
of ADs to counteract stress-induced impairment of hippocampal network function.
However, the observed effects of ADs are impossible to depend on enhanced
neurogenesis.
Keywords: hippocampus, trisynaptic circuit, activity propagation, stress, antidepressants, ketamine, voltage-
sensitive dye, imaging
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INTRODUCTION
Stress is a major environmental risk factor for the development
of several psychiatric diseases, including depression and anxiety
disorders (de Kloet et al., 2005; Krishnan and Nestler, 2008;
Popoli et al., 2012). To date, the first-line treatment for
most stress-related psychiatric disorders is administration of
antidepressants (ADs; Benkert and Hippius, 2012). While
intensive research has provided fundamental insights into stress-
induced brain abnormalities and mechanisms of AD action at
the molecular, cellular, and synaptic level (Castrén, 2005; de
Kloet et al., 2005; Krishnan and Nestler, 2008; Popoli et al.,
2012; Hill et al., 2015), the alterations in millisecond-scale
neuronal circuit dynamics that can arise from stress exposure
and underlie therapeutic actions of ADs are largely unknown.
Investigations on this topic appear crucial, since many symptoms
of psychiatric disorders and their pharmacological alleviation are
increasingly thought to be best reflected by changes in spatio-
temporal patterns of electrical neuronal activity (Castrén, 2005;
Airan et al., 2007; Karayiorgou et al., 2012; Monteggia et al.,
2014).
A brain structure that is highly sensitive to stress hormones,
involved in the regulation of stress responses, and most likely
a therapeutically relevant target of ADs is the hippocampus
(Andersen et al., 2007; Maggio and Segal, 2007; von Wolff et al.,
2011; Méndez et al., 2012; Hill et al., 2015). Stress can severely
affect the structural integrity of the hippocampal network and
it is widely accepted that at least a part of the resultant
neurophysiological changes contribute to the symptomatology
of depression and other stress-related psychiatric diseases (de
Kloet et al., 2005; Popoli et al., 2012). A major function of
the hippocampus is to process sensory information, to store
it if appropriate, and to transmit it to downstream brain
structures. Transfer of sensory information to the hippocampus
prominently takes place via perforant path fibers (originating
in entorhinal cortex layer II) that synapse on neurons of the
dentate gyrus (DG). The DG represents the first relay station of
the glutamatergic trisynaptic circuitry of the hippocampus (in
the following abbreviated HTC: perforant path→ DG→ area
CA3→ CA1 output subfield, Figure 1A; Andersen et al., 2007).
We recently developed a voltage-sensitive dye imaging
(VSDI) assay in mouse brain slices, allowing real-time
monitoring and, thus, the investigation of neuronal activity
propagations through the entire HTC network (‘‘HTC-Waves’’;
Stepan et al., 2012, 2015). In this assay (Figure 1), HTC-Waves
are triggered by theta-frequency stimulation of perforant
path fibers, mimicking synchronous theta-rhythmical spiking
of entorhinal layer II neurons, which exhibit such activity
during physiologically highly relevant theta oscillations in the
entorhinal-hippocampal system (Dickson et al., 2000; Mizuseki
et al., 2009; Quilichini et al., 2010; Burgalossi et al., 2011). Here,
by use of the HTC-Wave assay, we are the first to examine the
impact of chronic stress and concentration-dependent effects
of ADs on polysynaptic activity propagations through a major
input-output network of the hippocampus.
VSDI in brain slices has been already previously employed
to investigate stress and AD effects on hippocampal circuit
FIGURE 1 | Principle of the HTC-Wave Voltage-Sensitive Dye Imaging
(VSDI) assay in mouse hippocampal slices. (A,B) Experimental
arrangement used to obtain the data shown in (C) and (D) (modified from
Stepan et al., 2012). MF, mossy fiber; PP, perforant path; ROI, region of
interest; SC, Schaffer collateral; SL, stratum lucidum; SR, stratum radiatum;
Stim, extracellular electrical stimulation; TA, temporoammonic pathway.
(C) VSDI filmstrip of a submaximal HTC-Wave evoked by theta-frequency (5
Hz) electrical stimulation of the perforant path (stimulus 5). Only selected
imaging frames are shown (sampling time was 2.2 ms). Warmer colors
represent higher values of the fractional change in fluorescence (∆F/F ) of the
voltage-sensitive dye and, thus, stronger neuronal activity. For the appearance
of maximal (saturated) HTC-Waves see Stepan et al. (2012). (D) Depiction of
ROI-extracted fast, depolarization-mediated imaging signals (FDSs), which
reflect neuronal action potentials and glutamatergic excitatory postsynaptic
potentials (EPSPs). Note the typically increasing CA3 signals and the delayed
occurrence of CA1-FDSs, which predominantly derive from frequency
facilitation of neurotransmission at mossy fiber synapses onto CA3 pyramidal
neurons (cf., supplementary movie in Stepan et al., 2012).
dynamics (Airan et al., 2007). In this work, rats were
exposed to chronic mild stress or treated with fluoxetine
or imipramine for several days. The authors found that
a measure of local activity spread within the DG was
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decreased in slices from stressed animals and observed an
opposing effect in area CA1. Antipodal neurophysiological
changes were detected in slices from AD-treated animals. In
contrast to the present study, neuronal activity in the DG
and area CA1 was evoked independently from each other
by local electrical stimulation, thus excluding measurements
of activity propagation through the whole HTC network
and potential effects on the highly stress-sensitive CA3
circuitry.
To summarize our main results, we found that exposure of
mice to chronic social defeat stress leads to markedly weakened
HTC-Waves, while all eight ADs tested (belonging to different
chemical/functional classes) amplify the activity propagations in
CA regions at concentrations in the low micromolar range.
MATERIALS AND METHODS
Animals
For all experiments, adult male C57BL/6N mice (8 to
12 weeks old, obtained from the Max Planck Institute’s breeding
colony) and adult male CD-1mice (12 to 24 weeks old, purchased
fromCharles River) were used. All experimental procedures were
approved by the committee for the Care and Use of Laboratory
animals of the Government of Upper Bavaria, Germany.
Chronic Social Defeat Stress
The stress paradigm lasted 14–19 days and was conducted
as we described previously (Wagner et al., 2012). Briefly,
the experimental C57BL/6N mice were introduced into the
home cage of a dominant resident CD-1 mouse and defeated
shortly after. When the defeat was achieved, the animals
were separated by a wire mesh, preventing physical but
allowing sensory contact for 24 h. Each day, animals of the
stress group were defeated by another unfamiliar, dominant
resident mouse, excluding a repeated encounter throughout
the experiment. The daily defeat was performed between
11:00 am and 4:00 pm. Varying starting times reduced the
predictability of the stressor and, therefore, minimized a
potential habituation effect. Control mice were housed in their
home cages during the course of the experiment. Both stressed
and control animals were handled daily during the stress
procedure. At the day of VSDI experimentation, animals of the
stress group were not anymore defeated. VSDI measurements
were done between day 15 and 20 after the start of the stress
paradigm.
Preparation and Staining of Brain Slices
C57BL/6N mice were anesthetized with isoflurane and
decapitated. All following steps were done in ice-cold sucrose-
based saline saturated with carbogen gas (95% O2/5% CO2).
This saline (pH 7.4) consisted of (in mM): 87 NaCl, 2.5
KCl, 25 NaHCO3, 1.25 NaH2PO4, 0.5 CaCl2, 7 MgCl2, 25
glucose, and 75 sucrose. The hemispheres were prepared for
the slicing procedure by a special transversal cut, which is
sometimes called ‘‘magic cut’’ (Bischofberger et al., 2006).
We cut the hemispheres at angles optimized to conserve
the intrahippocampal axonal projections along the DG-
CA axis as best as possible. Subsequently, 350 µm-thick
horizontal slices were cut using a vibratome (HM650V,
Thermo Scientific). Slices were incubated in carbogenated
sucrose-based saline for 30 min at 34◦C. Subsequent staining
with the voltage-sensitive dye Di-4-ANEPPS (dissolved in
DMSO to a 20.8 mM stock solution) was carried out at
room temperature (23–25◦C). Slices were kept for 15 min in
carbogenated physiological saline containing Di-4-ANEPPS
(7.5 µg/ml, <0.1% DMSO). The physiological saline (pH 7.4)
consisted of (in mM): 125 NaCl, 2.5 KCl, 25 NaHCO3, 1.25
NaH2PO4, 2 CaCl2, 1 MgCl2, and 25 glucose. Afterwards,
slices were stored at room temperature for at least 30 min
in Di-4-ANEPPS-free carbogenated physiological saline
containing 0.6 µM bicuculline methiodide (BIM, for rationale
see ‘‘Discussion’’ Section).
VSDI
VSDI and data analysis were performed using the
MiCAM02 hard and software package (BrainVision).
The tandem-lens fluorescence microscope was equipped
with the MiCAM02-HR camera and the 2× and 1× lens
at the objective and condensing side, respectively (for
further technical details see http://www.scimedia.com).
Acquisition settings were as follows: 88 × 60 pixels frame
size, 36.4 × 40.0 µm pixel size, and 2.2 ms sampling
time.
Processing and Quantification of VSDI
Data
From VSDI signals, the fractional change in fluorescence (∆F/F)
was calculated and ∆F/F values were spatially and temporally
smoothed using a 3× 3× 3 average filter. VSDI signals presented
in images were smoothed with a 5 × 5 × 3 average filter. To
attenuate slow signal components produced from bleaching of
the dye and slight summation of 5 Hz neuronal responses (see
next paragraph), we afterwards applied a weak high-pass filter
of the MiCAM02 software (τ = 220 ms) to the imaging data.
Pixelation of images was reduced by the interpolation function
of the MiCAM02 software.
For analysis of neuronal population activity in hippocampal
subregions, standardized regions of interest (ROIs) were
manually set according to anatomical landmarks. The
circular CA3-ROI (r = 4 pixels) was positioned into the
CA3 region near the DG, but not overlapping with it.
The circular CA1-ROI (r = 4 pixels) was placed into
the CA1 subfield with a distance of approximately 200
µm from the visually identified distal end of the stratum
lucidum. Both ROIs spanned the stratum oriens, stratum
pyramidale, and stratum lucidum/radiatum. The DG-ROI,
which enclosed the fascia dentata (Figures 1A,B), was
created by the polygon-drawing function of the MiCAM02
software. The average of smoothed ∆F/F values within a
particular ROI served as final measure of neuronal population
activity.
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Brain Slice Experiments
All slice experiments were carried out at room temperature
and slices were continuously superfused with BIM (0.6 µM)-
containing carbogenated physiological saline (4–5 ml/min
flow rate). BIM never led to epileptiform activity in the
hippocampal subfields under study (for the appearance of
such activity see Stepan et al., 2012). HTC-Waves were
evoked by square pulse electrical stimuli (200 µs pulse width)
delivered at 5 Hz via a monopolar tungsten electrode (50
µm tip diameter, ∼0.5 MΩ nominal impedance) to the
visually identified perforant path near its entry zone to
the DG (Figures 1A,B). In all slices, perforant path fibers
which directly innervate CA3 pyramidal cells were cut at the
point where they exit the DG. Temporoammonic projections
were likewise functionally inactivated (Figures 1A,B). For the
pharmacological experiments, the intensity of perforant path
stimulation (15–35 V) was adjusted in a manner to produce
fast, depolarization-mediated imaging signals (FDSs) in the DG
with amplitudes of 50–80% of the highest attainable value.
These FDSs range within the linear upturn of the respective
input-output curve (Stepan et al., 2012). To obtain submaximal
HTC-Waves comprising CA1-FDSs with amplitudes of 0.1–0.3%
∆F/F, 4–7 consecutive stimulation pulses were delivered per
recording sequence to the perforant path (Figures 1C,D). The
number of consecutive stimulation pulses was held constant
within an experiment. Acquisitions were made every 2 min
and the amplitude values of the last DG-, CA3-, and CA1-
FDS within a recording sequence (Figure 1D) were determined
by means of the MiCAM02 software. As final measure of DG,
CA3, and CA1 activity, we calculated mean DG-, CA3-, and
CA1-FDS amplitude values over three consecutive acquisitions.
Drugs were bath applied to slices if baseline recording was
stable over 20 min (Figure 3A). For each pharmacological
condition, a maximum number of two slices per animal was
used.
For the experiments in slices from stressed/non-stressedmice,
we used a HTC-Wave assay, which was refined for group
comparisons. We established an experimental procedure, by
which inter-slice variability in HTC dynamics could be well
handled. For each animal, this procedure was applied to 2–3
slices. In particular, we delivered three trains of 15 stimulation
pulses (5 Hz stimulation, 3 min inter-train interval) to the
perforant path. The stimulation intensity was adjusted such
that the first DG-FDS within recording sequence one, two,
and three had an amplitude of approximately 0.35, 0.45, and
0.55% ∆F/F, respectively (Figure 2B). The resultant HTC-
Waves comprised CA3- and CA1-FDSs, which linearly increased
with increasing stimulation intensity (data not shown). For
quantification, we used the amplitude value of the first DG-
FDS, the mean amplitude value of the last three CA3-FDSs,
and the mean amplitude value of the last three CA1-FDSs
within a recording sequence. These values were averaged over
the three recording sequences. The resultant mean values in
turn were averaged over the 2–3 experiments conducted for
each animal, yielding the measure ‘‘Mean FDS amplitude’’
(Figure 2C). Healthiness of ‘‘stress’’ slices was comparable to
that of ‘‘control’’ slices, since the ranges of stimulation intensities
FIGURE 2 | Exposure of mice to chronic social defeat stress causes
markedly weakened HTC-Waves. (A) Data from body weight
measurements (body weight gain during stress/non-stress exposure; stress
(n = 7) vs. control (n = 6): t(11) = −4.6, p < 0.001; two-tailed unpaired t-test).
(B) Representative VSDI recording traces for control and stress conditions. For
both recording sequences, the intensity of perforant path stimulation (15
pulses at 5 Hz) was adjusted such that the first DG-FDS had an amplitude
of 0.45% ∆F/F. (C) Quantification of VSDI measurements (n = 6 animals/18
slices for the control group and n = 7 animals/19 slices for the stress group;
VSDI measures obtained from 2–3 slices per animal were averaged, leading to
n values of 6 and 7 for the control and stress group, respectively; stress vs.
control: CA3: t(11) = −5.0, p < 0.001; CA1: t(11) = −5.7, p < 0.001;
two-tailed unpaired t-tests). For a detailed description of how the measure
“Mean FDS amplitude” was calculated see “Materials and Methods”. (D)
Relationships between mean CA1-FDS amplitude and duration of
stress/non-stress exposure (p values were determined by linear
(Continued)
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FIGURE 2 | Continued
regression analyses). (E) In slices from both control and stressed mice, the
amplitude of CA1-FDSs linearly increased with the amplitude of CA3-FDSs.
Data were obtained by averaging the CA1- and CA3-FDS amplitude values for
electrical stimulus 1, 2, 3, . . ., 15 over the 18/19 experiments performed in
control/stressed mice, in which the amplitude of the first DG-FDS was
adjusted to ∼0.45% ∆F/F. (F) The typical increase in CA3- and CA1-FDSs
during 5 Hz perforant path stimulation is much weaker in slices from stressed
animals. (G) CA3/CA1 activity ratios for the experiments conducted in
control/stressed mice, in which the amplitude of the first DG-FDS was
adjusted to 0.45% ∆F/F (stress vs. control: t(11) = 3.5, p = 0.005; two-tailed
unpaired t-test). ∗∗p < 0.01, ∗∗∗p < 0.001; n.s., not statistically significant.
needed for evocation of the defined DG-FDSs were nearly
identical (6–32 V for ‘‘stress’’ slices and 7–36 V for ‘‘control’’
slices).
Chemicals
Amitriptyline hydrochloride, BIM, citalopram hydrobromide,
clomipramine hydrochloride, Di-4-ANEPPS, diazepam
(dissolved in DMSO to a 100 mM stock solution, ≤0.001%
final DMSO), DMSO, fluoxetine hydrochloride, fluvoxamine
maleate, haloperidol (dissolved in DMSO to a 100 mM stock
solution, ≤0.02% final DMSO), S-(+)-ketamine hydrochloride,
LiCl, tranylcypromine hydrochloride, venlafaxine hydrochloride,
and all salts for the saline solutions were purchased from Sigma-
Aldrich. ANA-12 and tianeptine sodium salt were from Tocris,
brain-derived neurotrophic factor (BDNF) from Biomol, and
isoflurane from Abbott.
Statistics
Statistical analyses were run in SigmaStat (Systat Software),
with significance declared at p < 0.05 (∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001; n.s., not statistically significant). Data are given
as mean ± SEM. Statistical tests are described in the respective
paragraphs of the results section and/or figure legends. In the
pharmacological experiments where ANOVAs were employed
for statistical evaluation, the one-sample t-test was used to
determine the concentration(s) at which a statistically significant
effect took place, given that the ANOVA passed (p< 0.05).
RESULTS
Exposure of Mice to Chronic Social Defeat
Stress Causes Markedly Weakened
HTC-Waves
We examined the impact of chronic social defeat stress (14–19
days) on HTC-Waves. To assure ‘‘pure’’ activity propagations
through the HTC network, perforant path fibers which directly
innervate CA3 pyramidal cells were cut at the point where
they exit the DG. Temporoammonic projections were likewise
functionally inactivated (Figures 1A,B (scissors)). As a real-
time measure of neuronal population activity in the DG and
CA areas, we employed the amplitude of fast, depolarization-
mediated VSDI signals (FDSs, Figure 1D), which reflect action
potentials and glutamatergic excitatory postsynaptic potentials
(EPSPs; Airan et al., 2007; von Wolff et al., 2011; Stepan et al.,
2012). For more detailed information about the characteristics
and physiological relevance of HTC-Waves see ‘‘Discussion’’
Section and Stepan et al. (2012, 2015). The stress paradigm
used reliably induces changes in metabolic and endocrine
parameters, which typically occur with chronic stress exposure.
Furthermore, it causes an increased stress reactivity and
an impairment of hippocampus-dependent cognitive abilities
(Wang et al., 2011; Wagner et al., 2012). Body weight
measurements confirmed that the mice under investigation
were profoundly stressed (Figure 2A; Wang et al., 2011). As
evident from a pronounced decrease of CA3- and CA1-FDSs,
the stress procedure led to considerably weakened HTC-Waves
when compared to control conditions (Figures 2B,C). Linear
regression analyses showed that there was no relationship
between this effect and the duration of stress exposure
(Figure 2D).
Further analyses revealed that in slices from both control and
stressed mice the amplitude of CA1-FDSs linearly increased with
the amplitude of CA3-FDSs (Figure 2E). However, the typical
initial increase in CA3- and CA1-FDSs during 5 Hz perforant
path stimulation, which predominantly derives from frequency
facilitation of neurotransmission at mossy fiber synapses onto
CA3 pyramidal neurons (Stepan et al., 2012), was much weaker
in slices from stressed animals (Figure 2F). We also calculated
CA3/CA1 activity ratios for ‘‘control’’ and ‘‘stress’’ slices. These
ratios were determined by dividing the mean amplitude value of
the last three CA3-FDSs by the mean amplitude value of the last
three CA1-FDSs within a recording sequence and by averaging
the resultant quotients over the 2–3 experiments conducted
for each animal. The CA3/CA1 activity ratio was higher in
the stress group (Figure 2G). These findings strongly suggest
that the stress effect on HTC-Waves originated from impaired
neurotransmission in both area CA3 and area CA1.
ADs Exert Enhancing Effects on
HTC-Waves
In another set of experiments, we investigated potential
effects of eight clinically used ADs on HTC-Waves. The
ADs were the tricyclics amitriptyline and clomipramine, the
selective serotonin reuptake inhibitors fluoxetine, citalopram,
and fluvoxamine, the selective serotonin/norepinephrine
reuptake inhibitor venlafaxine, the selective serotonin reuptake
enhancer tianeptine, and the monoamine oxidase A and B
inhibitor tranylcypromine (McEwen et al., 2010; Benkert
and Hippius, 2012). The ADs were tested at 0.1, 0.5, 1,
5, 10, and mostly also at 15 and 20 µM. As illustrated
for fluoxetine (10 µM), which significantly increased
CA3- and CA1-FDSs, drugs were bath applied to slices if
baseline recording of HTC-Waves was stable over 20 min
(Figure 3A).
With the exception of fluvoxamine (10 µM) and venlafaxine
(1 and 10 µM), the ADs did not affect DG-FDSs (Figures 3A,B
(left panels)). In contrast, at concentrations in the low
micromolar range, all ADs led in the same experiments to an
enhancement of CA1-FDSs (Figures 3A,B (black bars in right
panels)). Interestingly, only the data obtained for fluoxetine,
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FIGURE 3 | Time course of fluoxetine effects (A) and concentration-dependent impact of amitriptyline, clomipramine, fluoxetine, citalopram,
fluvoxamine, venlafaxine, tianeptine, and tranylcypromine (B) on HTC-Waves in slices from non-stressed mice. (A) As done with all other drugs probed,
fluoxetine (10 µM) was bath applied to slices (n = 7) if baseline recording of HTC-Waves was stable over 20 min. Subsequent recording time was always 40 min.
Data were normalized to mean baseline FDS amplitude values. (B) For statistical analysis, one-way ANOVAs were applied to the DG-, CA3-, and CA1-FDS data sets
(% change in FDS amplitude, minutes 42–60 vs. minutes 0–18 of VSDI recording (A)) covering the whole range of concentrations probed. Due to its very strong
effects at 5 and 10 µM, tianeptine was no longer tested at 15 and 20 µM. DG: fluvoxamine: F(6,50) = 4.2, p = 0.002; 10 µM, t(7) = −5.3, p = 0.001; venlafaxine:
F(6,52) = 2.7, p = 0.021; 1 µM, t(8) = −3.1, p = 0.014; 10 µM, t(8) = −9.5, p < 0.001; CA3: fluoxetine: F(6,47) = 2.5, p = 0.033; 10 µM, t(6) = 3.5, p = 0.013; 15 µM,
t(6) = 3.4, p = 0.013; 20 µM, t(7) = 3.4, p = 0.011; venlafaxine: F(6,52) = 4.2, p = 0.002; 0.5 µM, t(9) = 2.6, p = 0.027; 5 µM, t(7) = 3.0, p = 0.019; tianeptine:
F(4,30) = 8.8, p < 0.001; 0.5 µM, t(6) = 2.8, p = 0.031; 1 µM, t(6) = 2.6, p = 0.043; 5 µM, t(6) = 4.0, p = 0.007; 10 µM, t(6) = 4.4, p = 0.005;
(Continued)
Frontiers in Neural Circuits | www.frontiersin.org 6 November 2015 | Volume 9 | Article 70
Stepan et al. Opposing stress/antidepressant effects on HTC-Waves
FIGURE 3 | Continued
tranylcypromine: F(6,56) = 3.7, p = 0.004; 0.1 µM, t(7) = −4.6, p = 0.002;
CA1: amitriptyline: F(6,46) = 4.2, p = 0.002; 10 µM, t(6) = 3.3, p = 0.016;
clomipramine: F(6,59) = 2.8, p = 0.02; 15 µM, t(8) = 2.8, p = 0.023; fluoxetine:
F(6,47) = 4.6, p < 0.001; 1 µM, t(7) = 2.4, p = 0.047; 5 µM, t(7) = 3.3, p =
0.013; 10 µM, t(6) = 5.2, p = 0.002; 15 µM, t(6) = 4.2, p = 0.006; 20 µM, t(7)
= 3.4, p = 0.01; citalopram: F(6,51) = 2.3, p = 0.049; 5 µM, t(9) = 3.7, p =
0.005; 15 µM, t(7) = 4.9, p = 0.002; fluvoxamine: F(6,50) = 5.9, p < 0.001; 10
µM, t(7) = 2.9, p = 0.023; 15 µM, t(7) = 3.1, p = 0.017; 20 µM, t(8) = 3.2, p =
0.016; venlafaxine: F(6,52) = 4.8, p < 0.001; 0.5 µM, t(9) = 4.6, p = 0.001; 5
µM, t(7) = 3.0, p = 0.019; 15 µM, t(6) = 2.9, p = 0.014; 20 µM, t(7) = 3.4, p =
0.022; tianeptine: F(4,30) = 11.2, p < 0.001; 0.5 µM, t(6) = 3.6, p = 0.012; 1
µM, t(6) = 5.8, p = 0.001; 5 µM, t(6) = 4.6, p = 0.004; 10 µM, t(6) = 4.6, p =
0.004; tranylcypromine: H(6) = 18.6, p = 0.005 (Kruskal-Wallis ANOVA on
ranks); 0.1 µM, t(7) = −3.6, p = 0.008; 10 µM, t(7) = 4.4, p = 0.003. Number
of experiments (slices) for 0.1, 0.5, 1, 5, 10, 15, and 20 µM: amitriptyline: n =
8, 8, 8, 7, 7, 7, and 8; clomipramine: n = 9, 12, 10, 10, 8, 9, and 8; fluoxetine:
n = 8, 8, 8, 8, 7, 7, and 8; citalopram: n = 8, 9, 8, 10, 8, 8, and 7; fluvoxamine:
n = 8, 8, 8, 8, 8, 8, and 9; venlafaxine: n = 8, 10, 9, 8, 9, 7, and 8; tianeptine:
n = 7, 7, 7, 7, and 7; tranylcypromine: n = 8, 10, 8, 8, 8, 13, and 8. For each
pharmacological condition, a maximum number of two slices per animal was
used. (C) Relative change in CA3/CA1 activity ratios in the presence of 10 µM
amitriptyline (a), 15 µM clomipramine (b), 20 µM fluoxetine (c), 15 µM
citalopram (d), 20 µM fluvoxamine (e), 5 µM venlafaxine (f ), 5 µM tianeptine
(g), and 10 µM tranylcypromine (h; amitriptyline: t(6) = −5.4, p = 0.002;
clomipramine: t(8) = −7.8, p < 0.001; fluoxetine: t(7) = −6.1, p < 0.001;
citalopram: t(7) = −5.1, p = 0.001; fluvoxamine: t(8) = −5.8, p < 0.001;
venlafaxine: t(7) = −3.9, p = 0.008; tianeptine: t(6) = −8.6, p < 0.001;
one-sample t-tests). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
fluvoxamine, and tianeptine are reconcilable with a classical
dose-response relationship. Fluoxetine (10, 15, and 20 µM),
venlafaxine (0.5 and 5 µM), and tianeptine (0.5, 1, 5, and 10
µM) additionally increased CA3-FDSs (Figures 3A,B (black bars
in middle panels)). Another finding was that tranylcypromine
(0.1 µM) decreased CA3- and CA1-FDSs (Figure 3B). With the
exception of tranylcypromine, all ADs reduced the CA3/CA1
activity ratio (Figure 3C).
Taken together, at concentrations in the low micromolar
range (but not at 0.1 µM and mostly also not at 0.5 µM),
all ADs caused an amplification of HTC-Waves in the CA1
output subfield of the hippocampus. At some of the effective
doses, fluoxetine, venlafaxine, and tianeptine also provoked
an enhancement of CA3 activity. A close inspection of the
data depicted in Figure 3B suggests that the latter effect,
although lacking statistical significance, likewise occurred with
the other ADs.
Lithium, BDNF, and Ketamine Exert
Enhancing Effects on HTC-Waves
We further tested whether other neuroactive factors, which
do not belong to the group of classical ADs, but exhibit
antidepressant-like actions, exert enhancing effects on HTC-
Waves. We examined potential effects of the mood stabilizer
lithium (Moore et al., 2002), the neurotrophin BDNF (Shirayama
et al., 2002), and the fast-acting ‘‘antidepressant’’ ketamine
(Autry et al., 2011) on the activity propagations. In fact, without
changing DG-FDSs, lithium (0.5 and 1 mM; Moore et al.,
2002), BDNF (0.4 nM; Kang and Schuman, 1995), and ketamine
(20 µM; Autry et al., 2011) increased CA1-FDSs. BDNF and
ketamine additionally caused an enhancement of CA3-FDSs
(Figure 4A). As observed for most of the ADs, all three
compounds reduced the CA3/CA1 activity ratio (Figure 4B).
Haloperidol and Diazepam Weaken
HTC-Waves
The findings described above led us to hypothesize that, in
comparison to other psychiatric drugs (e.g., antipsychotics and
anxiolytics), an enhancing influence on HTC-Waves might be a
characteristic feature of ADs. On this account, we next performed
experiments with the classical antipsychotic haloperidol and the
widely used anxiolytic diazepam (Benkert and Hippius, 2012). In
line with our hypothesis, haloperidol decreased DG-, CA3-, and
CA1-FDSs in a concentration-dependent manner. Consistent
with its potentiating effect on GABAA receptor function and
our previous demonstration that HTC-Waves are confined in
their strength by GABAergic neurotransmission (Stepan et al.,
2012), also diazepam (0.1 and 1 µM; Rupprecht et al., 2009)
weakened the activity propagations (Figure 4C). In contrast to
ADs, lithium, BDNF, and ketamine, haloperidol and diazepam
increased the CA3/CA1 activity ratio (Figure 4B).
Fluoxetine Exerts Enhancing Effects on
HTC-Waves in Slices from Stressed Mice
Next, we addressed the question of whether ADs also exert
enhancing effects on HTC-Waves in slices obtained from
chronically stressed mice. Hereunto, we investigated the impact
of fluoxetine (10 µM) on the activity propagations. We chose
fluoxetine since it represents the classical AD, which showed the
most pronounced effects on HTC-Waves (Figure 3B). Indeed,
as observed in naive slices (for statistics see Figure 3), fluoxetine
increased CA3- and CA1-FDSs in slices from stressed animals
(Figure 5 (middle bars)).
The TrkB Receptor Antagonist ANA-12
Prevents Fluoxetine Effects on HTC-Waves
There is substantial evidence that activation of the BDNF
receptor TrkB is involved in the mechanisms of action of ADs
(Castrén and Rantamäki, 2010). Our finding that BDNF, like
ADs, increases FDSs in CA regions led us to test a possible
contribution of TrkB activation to the AD effects on HTC-
Waves. Hereunto, we preincubated slices for at least 1 h with
the TrkB antagonist ANA-12 (10 µM; Longo and Massa, 2013).
Afterwards, we again investigated the impact of fluoxetine (10
µM, for rationale see above) on HTC-Waves. As shown in
Figure 5 (right bars), ANA-12 prevented the fluoxetine-induced
amplification of CA1- and CA3-FDSs.
DISCUSSION
In the present study, we show that eight clinically used ADs
(although belonging to different chemical/functional classes)
cause an amplification of HTC-Waves in CA regions (invariably
in the CA1 subfield and also partly in area CA3). However, these
effects only occurred at concentrations in the low micromolar
range, with the exception of venlafaxine and tianeptine, which
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FIGURE 4 | Impact of lithium, BDNF, ketamine, haloperidol, and diazepam on HTC-Waves in slices from non-stressed mice. (A) For statistical analysis,
one-sample t-tests were used (lithium (n = 7 slices for 0.5 and 1 mM): CA1: 0.5 mM, t(6) = 2.5, p = 0.045; 1 mM, t(6) = 7.5, p < 0.001; BDNF (n = 8 slices): CA3:
t(7) = 3.6, p = 0.008; CA1: t(7) = 3.4, p = 0.011; ketamine (n = 8 slices): CA3: t(7) = 4.9, p = 0.002; CA1: t(7) = 4.2, p = 0.004). (B) Relative change in CA3/CA1
activity ratios in the presence of 1 mM lithium (a), 0.4 nM BDNF (b), 20 µM ketamine (c), 20 µM haloperidol (d), and 1 µM diazepam (e; lithium: t(6) = −9.7, p <
0.001; BDNF: t(7) = −3.5, p = 0.01; ketamine: t(7) = −3.6, p = 0.009; haloperidol: t(5) = 2.7, p = 0.035; diazepam: t(5) = 3.3, p = 0.029; one-sample t-tests). (C)
Statistical evaluation of haloperidol effects was performed as done for ADs. For diazepam effects, the one-sample t-test was used (haloperidol: DG: F(6,43) = 17.8,
p < 0.001; 10 µM, t(7) = −4.3, p = 0.003; 15 µM, t(5) = −4.8, p = 0.005; 20 µM, t(5) = −10.1, p < 0.001; CA3: F(6,43) = 4.3, p = 0.002; 10 µM, t(7) = −3.7, p =
0.007; 15 µM, t(5) = −3.0, p = 0.028; 20 µM, t(5) = −8.7, p < 0.001; CA1: F(6,43) = 3.6, p = 0.005; 10 µM, t(7) = −3.5, p = 0.01; 15 µM, t(5) = −3.5, p = 0.017; 20
µM, t(5) = −9.0, p < 0.001; number of experiments (slices) for 0.1, 0.5, 1, 5, 10, 15, and 20 µM: n = 8, 8, 6, 8, 8, 6, and 6; diazepam (n = 7 slices for 0.1 µM and
n = 6 slices for 1 µM): DG: 1 µM, t(5) = −4.1, p = 0.009; CA3: 0.1 µM, t(6) = −4.9, p = 0.003; 1 µM, t(5) = −7.8, p < 0.001; CA1: 0.1 µM, t(6) = −5.7, p = 0.001; 1
µM, t(5) = −8.4, p < 0.001). For each pharmacological condition, a maximum number of two slices per animal was used. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
additionally slightly boosted the activity propagations at 0.5 µM.
Low micromolar brain concentrations of ADs are clinically
relevant (Strauss et al., 1997; Bolo et al., 2000; Henry et al.,
2005; Méndez et al., 2012), but considerably higher than those
required for monoamine reuptake inhibition (IC50 values for
serotonin reuptake inhibition by amitriptyline, clomipramine,
fluoxetine, citalopram, and fluvoxamine (in nM): 39, 1.5, 6.8,
1.8, and 3.8, respectively (Hyttel, 1993)). In combination with
our findings that also the serotonin reuptake enhancer tianeptine
and BDNF increase CA3- and CA1-FDSs and that the TrkB
receptor antagonist ANA-12 prevents the effects of fluoxetine
(10 µM), it is thus possible that the AD effects observed do
not depend on enhanced monoaminergic neurotransmission,
but, at least in part, on increased TrkB signaling. Consistently,
activation of TrkB is involved in AD actions and also lithium
and ketamine, which likewise amplified HTC-Waves, enforce
TrkB signaling (Castrén and Rantamäki, 2010; Autry et al.,
2011).
Notably, only the data obtained for fluoxetine, fluvoxamine,
and tianeptine are reconcilable with a classical dose-response
relationship. The lack of such a relationship observed for
the other five ADs and the fact that three compounds
produced a boosting effect on HTC-Waves merely at one
of the concentrations probed presumably rely on the partly
intricate and heterogeneous pharmacological properties of ADs
and the high structural and functional complexity of the
Frontiers in Neural Circuits | www.frontiersin.org 8 November 2015 | Volume 9 | Article 70
Stepan et al. Opposing stress/antidepressant effects on HTC-Waves
HTC network (i.e., trisynaptic interconnections and appendant
excitatory/inhibitory microcircuits; Andersen et al., 2007). This
might also be the reason why fluvoxamine (10 µM), venlafaxine
(1 and 10 µM), and tranylcypromine (0.1 µM) decreased DG-
or CA3- and CA1-FDSs (Figure 3B). For instance, beside
its enhancing action on monoaminergic neurotransmission,
amitriptyline inhibits nicotinic acetylcholine receptors, use-
dependently blocks voltage-gated sodium channels, and activates
TrkB receptors with different potencies (Schofield et al., 1981;
Huang et al., 2006; Jang et al., 2009). Similar (but not identical)
pharmacological profiles have been described for some of the
other ADs tested, whereas those of venlafaxine, tianeptine, and
tranylcypromine are considerably different (Huang et al., 2006;
Castrén and Rantamäki, 2010; McEwen et al., 2010; Benkert and
Hippius, 2012). It is thus conceivable that a particular AD (at
concentration A) exerts an enhancing effect on HTC-Waves,
while, at a higher concentration B, this effect is less pronounced
or absent (cf., Figure 3B (upper right panel)). Another AD in
turn might show a varying effect pattern. Therefore, we deem it
extremely challenging, if not impossible, to accurately predict AD
actions on large/meso-scale neuronal network dynamics from
known effects at the molecular/cellular level, given that these
effects presumably have not been completely elucidated until
now.
We yield evidence that, in comparison to antipsychotics and
anxiolytics, enhancing effects on HTC-Waves are a characteristic
feature of ADs and other neuroactive factors, which show
antidepressant-like actions. This evidence is given by our
findings that lithium, BDNF, and ketamine also cause an
amplification of HTC-Waves, whereas haloperidol and diazepam
weaken the activity propagations. The data obtained for
haloperidol are noteworthy, since an impaired hippocampal
FIGURE 5 | Enhancing effects of fluoxetine on HTC-Waves occur in
slices from chronically stressed mice and are prevented by the TrkB
receptor antagonist ANA-12. For group comparisons, two-tailed unpaired
t-tests were used. For statistical analyses of fluoxetine effects in slices (n = 8)
from stressed mice and ANA-12-treated slices (n = 11), one-sample t-tests
were employed (stress: CA3: t(7) = 2.4, p = 0.048; CA1: t(7) = 4.7, p = 0.002;
ANA-12: DG: t(10) = −3.8, p = 0.003; for statistics of fluoxetine effects in naive
slices see Figure 3; ANA-12 vs. naive: CA3: t(16) = −2.8, p = 0.012; CA1:
t(16) = −3.4, p = 0.003). For each pharmacological condition, a maximum
number of two slices per animal was used. ∗p < 0.05, ∗∗p < 0.01; n.s., not
statistically significant.
gating of sensory information flow from the entorhinal cortex
to downstream brain structures has been implicated in the
pathophysiology of schizophrenia (e.g., Javanbakht, 2006).
All slice experiments in the present study were performed
in the presence of BIM (0.6 µM). We used the competitive
GABAA receptor antagonist BIM at this weakly blocking dose
(Stepan et al., 2012) for the following reasons. First, compared
to the relatively short axons of most hippocampal GABAergic
interneurons (Andersen et al., 2007), projections from excitatory
neurons are cut to a greater extent during preparation of slices.
This probably leads to an artificial enhancement of inhibition in
large-scale hippocampal circuits in vitro (e.g., Iijima et al., 1996).
And second, the voltage-sensitive dye Di-4-ANEPPS possibly
slightly potentiated GABAA receptor function (Mennerick et al.,
2010). Hence, BIM most likely gave rise to more physiological
conditions, rather than qualitatively artificial pharmacological
effects. Consistently, HTC-Waves were weakened by the GABAA
receptor potentiator diazepam.
We revealed that chronic social defeat stress causes markedly
attenuated HTC-Waves, providing direct evidence that chronic
stress can depress neuronal signal flow through the HTC.
Furthermore, this finding suggests that the enhancing effects of
ADs on HTC-Waves are therapeutically relevant. Importantly,
fluoxetine also boosted CA3- and CA1-FDSs in slices from
stressed mice and the stress paradigm used causes impaired
hippocampus-dependent cognitive abilities, representing
a typical symptom of depression and other stress-related
psychiatric disorders (Wang et al., 2011;Wagner et al., 2012). But
how could the AD effects observed contribute to an alleviation
of this symptom? It is tempting to speculate that a strengthening
of activity-dependent neuroplastic processes plays a critical
role (Castrén, 2005). For instance, NMDA receptor-dependent
long-term potentiation (LTP) at CA3-CA1 synapses (CA1 LTP),
which is widely accepted to be crucial for some hippocampus-
dependent cognitive abilities (Burgess et al., 2002), can be
induced by HTC-Waves (Stepan et al., 2012) and possesses
the properties of ‘‘cooperativity’’ and ‘‘associativity’’ (Bliss and
Collingridge, 1993). Therefore, weakened activity propagations
through the HTC should be less effective in the induction of CA1
LTP, whereas enhancing AD effects on them probably counteract
this impairment. In this context, it is important to mention that
a recent publication likewise points to an enhancement of
CA1 activity by ADs. This study specifically investigated AD
actions on CA1 GABAergic neurotransmission (Méndez et al.,
2012). The effects observed by Méndez et al. (2012) did not
depend on enhanced monoaminergic neurotransmission and
required AD concentrations in the low micromolar range.
Notably, investigations in humans revealed that fluoxetine and
fluvoxamine reach low micromolar concentrations (10–15 µM;
cf., Figure 3B) in the brain after continuous drug administration
for 30 days or longer, matching the time point at which AD
therapy usually starts to be effective. One or two days after
start of treatment, the brain concentration is much lower
(low to intermediate nanomolar range; Strauss et al., 1997;
Bolo et al., 2000). It is thus conceivable that the onset of
beneficial AD actions in part reflects acute drug effects on
brain physiology, as it is the case for ketamine. These remarks
Frontiers in Neural Circuits | www.frontiersin.org 9 November 2015 | Volume 9 | Article 70
Stepan et al. Opposing stress/antidepressant effects on HTC-Waves
justify the investigation of fast modulatory actions of ADs
on neurophysiological processes, as done here and in many
previous studies (e.g., Schofield et al., 1981; Jang et al., 2009;
Méndez et al., 2012). However, further work using chronic
AD administration is needed to corroborate the potential
therapeutic relevance of the enhancing AD effects on HTC-
Waves.
As already mentioned in the introduction section, also
Airan et al. (2007) employed VSDI in brain slices to examine
chronic stress and AD effects on hippocampal circuit dynamics.
However, due to the partly big differences in the experimental
design (see Introduction), a direct comparison with our findings
is hardly achievable. Yet, if the measure ‘‘activity percolation’’
through area CA1 should reflect activity strength, our results
do not fit to those of Airan et al. (2007). This is because
our data point to an impaired neurotransmission in area CA1
of stressed mice and an opposite scenario in the presence
of ADs (Figures 2G, 3C). In contrast, Airan et al. reported
an increased ‘‘activity percolation’’ in slices from stressed
rats, which is counterintuitive with regard to the well-known
detrimental actions of chronic stress on the structural and
functional integrity of the hippocampus, and observed an
antipodal effect if animals were treated with fluoxetine or
imipramine. However, one has to consider that Airan and
colleagues induced CA1 activity by single-pulse stimulation of
the pyramidal cell layer and the ADs were most likely washed
out from their slice preparations. CA1 activity in our study
resulted from burst firing of CA3 pyramidal neurons, which is
a typical discharge pattern of these cells (Stepan et al., 2012). An
identical comparison for the DG data cannot be drawn, since we
adjusted DG activity in slices from stressed mice to predefined
values.
In summary, we provide evidence for shared modulatory
effects of ADs on HTC dynamics that counteract stress-induced
impairment of hippocampal network function. These effects,
which might be valuable for the screening for novel ADs,
point to a circuit-level mechanism of ADs in the entorhinal-
hippocampal system to alleviate cognitive dysfunctions often
observed with depression and other stress-related psychiatric
conditions. However, these effects cannot depend on enhanced
neurogenesis (Hill et al., 2015). Hence, our work highlights the
importance of circuit-centered approaches, complementary to
investigations at the molecular/cellular level and brain imaging
studies, in order to achieve a comprehensive understanding
of how environmental risk factors can translate into brain
disease states and how psychiatric drugs mediate their beneficial
actions.
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